Glucosentient, Inc.

CHAMPAIGN, IL 61820

SBIR Award Summary

Total Number of Awards 6
Total Value of Awards $1.66MM
First Award Date 01/01/12
Most Recent Award Date 04/01/17

Key Personnel

Last Name Name Awards Contact
Lan Tian Lan 8 Message

6 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-16-302
Budget: 04/01/17 - 03/31/18
PI: Tian Lan

Project Summary/Abstract Phenylketonuria (PKU) is a serious inborn metabolic disorder affecting 1 out of every 15,000 children born in the U.S. annually. Characteristic effect of PKU is the impaired capability of the body to convert the amino acid phenylalanine (Phe) to tyrosine and, as a result, Phe level is elevated in the blood stream. While...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-15-270
Budget: 08/01/16 - 07/31/17
PI: Tian Lan

Project Summary/Abstract The objective of this Phase I STTR project is to demonstrate feasibility of developing a selective,affordable, and pocket-sized device to enable regular and quantitative monitoring of both Li+ and Na+ levels inthe blood of patients with bipolar disorder (BD), which is one of the most common mental illnesses affectingover...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-12-088
Budget: 07/01/13 - 12/31/13
PI: Tian Lan

DESCRIPTION (provided by applicant): While the high costs of healthcare in the U.S. can be felt by everyone in the country, the economic impact to patients with kidney failure is particularl significant as dialysis treatments can reach $85,000 annually, with transplantation being the only known cure. Therefore, kidney transplants today make up m...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-122
Budget: 04/15/13 - 03/14/14
PI: Tian Lan

DESCRIPTION: Substance use disorder (SUD) is a major health problem with direct and indirect impact on healthcare and societal cost that is estimated at over $181 billion annually in the United States. Opioids are the second most abused substances and buprenorphine (BUP) is an effective and safe medication for opioid dependence. However, BUP re...

Phase 2 SBIR

Agency: National Science Foundation
Topic: BC-2013
Budget: 01/01/13 - 12/31/13
PI: Tian Lan

This Small Business Innovation Research (SBIR) Phase II project is aiming to develop and validate a point-of-care monitoring for tacrolimus, an immunosuppressive medication widely used by organ transplant patients. The product being developed combines the existing, well-developed and low cost glucose meter technology with the gold standard immun...

Phase 1 SBIR

Agency: National Science Foundation
Topic: BC-2012
Budget: 01/01/12 - 12/31/12
PI: Tian Lan

This Small Business Innovation Research Phase I project aims to develop a new technology to utilize ubiquitous personal glucose meters (PGMs) for inexpensive and convenient at-home tests of the drug theophylline. Theophylline has been widely used to treat asthma and chronic obstructive pulmonary diseases. It has a narrow effective range and adve...